Matthew W Boudreau

11PUBLICATIONS
29CO-AUTHORS
Biologically active moleculesCharacterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 25, 2026
Positive selection screen identifies natural product β-catenin inactivators.

|Sep 05, 2025
Positive Selection Screen for Natural Product β-Catenin Inactivators.

Matthew W Boudreau, Vitor F Freire, Sophie C Corbett

|Mar 03, 2025
Single Dose of a Small Molecule Leads to Complete Regressions of Large Breast Tumors in Mice.

Michael P Mulligan, Matthew W Boudreau, Brooke A Bouwens

|Jul 31, 2023
Plasma Membrane Channel TRPM4 Mediates Immunogenic Therapy-Induced Necrosis.

Santanu Ghosh, Rachel Yang, Darjan Duraki

|Jul 11, 2022
Evolution of 3-(4-hydroxyphenyl)indoline-2-one as a scaffold for potent and selective anticancer activity.

Matthew W Boudreau, Paul J Hergenrother

|Apr 25, 2022
Engaging the Medicinal Chemists of Tomorrow.

Lori Ferrins, Erika Araujo, Matthew W Boudreau

Pageof 2

Frequent Collaborators

6 joint publications

Paul J Hergenrother

3 joint publications

Margaret E Olson

3 joint publications

Lori Ferrins

2 joint publications

Darjan Duraki